Universidad de Guayaquil-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2016

  1. Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America

    Pharmacogenomics

  2. Relevancia de la ancestría para la variabilidad de polimorfismos de las enzimas metabolizadoras de fármacos CYP2C9, CYP2C19 y CYP2D6 en una población multiétnica de Costa Rica

    Revista de Biologia Tropical, Vol. 64, Núm. 3, pp. 1067-1076

  3. To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population

    OMICS A Journal of Integrative Biology, Vol. 20, Núm. 12, pp. 699-710

2013

  1. Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: The CEIBA cocktail

    Drug Metabolism and Drug Interactions, Vol. 28, Núm. 3, pp. 135-146

2012

  1. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 5, pp. 637-644

  2. Pharmacogenetics in Latin American populations: Regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders

    Drug Metabolism and Drug Interactions